Cargando…

Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-deprivation therapy. To investigate the metabolism regulation effects on androgen-independent growth of prostate cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Lei, Xing, Zhaoquan, Guo, Zhaoxin, Fang, Zhiqing, Jiao, Wei, Guo, Xiaoyu, Xu, Zhonghua, Fang, Zhenghui, Holmberg, Anders, Nilsson, Sten, Liu, Zhaoxu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567093/ https://www.ncbi.nlm.nih.gov/pubmed/23409045 http://dx.doi.org/10.1371/journal.pone.0055790

Ejemplares similares

Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation
por: Guo, Zhaoxin, et al.
Publicado: (2015)

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
por: Fang, Zhiqing, et al.
Publicado: (2013)

XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
por: Xing, Zhaoquan, et al.
Publicado: (2010)

Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway
por: Guo, Zhaoxin, et al.
Publicado: (2015)

LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression
por: Meng, Liwei, et al.
Publicado: (2020)

Upregulation of AQP2 mediated by transcription factor FOXO1 inhibits TGF-β-induced fibrosis in human urothelial cells
por: Qiu, Yue, et al.
Publicado: (2021)

The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987)

Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)
por: Noguchi, Shinzaburo, et al.
Publicado: (1993)

Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting FOXO3
por: Meng, Liwei, et al.
Publicado: (2021)

Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.
por: Joffe, B. I., et al.
Publicado: (1988)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

DSmishSMS-A System to Detect Smishing SMS
por: Mishra, Sandhya, et al.
Publicado: (2021)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Impact of somatostatin interneurons on interactions between barrels in plasticity induced by whisker deprivation
por: Dobrzanski, G., et al.
Publicado: (2022)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

DX centers
por: Munoz Merino, Elias
Publicado: (1994)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

SMS Messaging Applications
por: Pero, Nicola
Publicado: (2009)

SMS 2 administration
por: Lubanski, Mike, et al.
Publicado: (2000)

SMS Scans in ATLAS
por: Yamanaka, Takashi
Publicado: (2013)

SMS Scans in CMS
por: Strobbe, Nadja
Publicado: (2013)

The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer.
por: Iftikhar, S. Y., et al.
Publicado: (1991)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Androgen deprivation therapy increases brain ageing
por: Plata-Bello, Julio, et al.
Publicado: (2019)

Androgen Deprivation Therapy–Induced Cardiovascular Disease
por: Dhanushkodi, Manikandan
Publicado: (2016)

Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020)

Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers
por: Fang, Dong, et al.
Publicado: (2019)

Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer
por: Ishizaki, Fumio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oofn2lc99s8sq3vlb3hcj7uaju